Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease

Published experience with carfilzomib in patients with relapsed/refractory multiple myeloma (RRMM) and extramedullary disease (EMD) is still limited. The current study aimed to assess the efficacy and safety of carfilzomib containing therapy regimens in EMD. We retrospectively analyzed 45 patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Zhou, Xiang, Flüchter, Patricia, Nickel, Katharina, Meckel, Katharina, Messerschmidt, Janin, Böckle, David, Knorz, Sebastian, Steinhardt, Maximilian Johannes, Krummenast, Franziska, Danhof, Sophia, Einsele, Hermann, Kortüm, K. Martin, Rasche, Leo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225914/
https://ncbi.nlm.nih.gov/pubmed/32340174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12041035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados